Cordis today announced the initiation of a global registry to track real-world outcomes for the Selution SLR drug-eluting ...

After six years, Cardinal Health is dropping its Cordis medical device division, makers of cardiovascular catheters and diagnostic hardware, in a $1 billion deal with private equity firm Hellman ...

Cardinal Health said March 12 it is selling its Cordis medical device business to private equity firm Hellman & Friedman for roughly $1 billion. Cordis makes cardiology and endovascular devices.

Cardinal Health has completed the sale of its Cordis medical device business to private equity firm Hellman & Friedman for about $1 billion, the healthcare services company said Aug 2.

Without Cordis, the conglomerate would still have 11 businesses devoted to medical devices and diagnostics including BioSense Webster, as well as the troubled orthopedic and neurological focused ...